HFSA designates right heart failure as a distinct clinical syndrome
The Heart Failure Society of America has released a new scientific statement urging clinicians to recognize and manage right heart failure as an independent clinical condition.
The Heart Failure Society of America (HFSA) issued a scientific statement on October 27, 2026, calling for right heart failure to be classified as a distinct clinical syndrome. The report seeks to shift clinical focus toward identifying and managing the condition as a unique entity rather than solely as a byproduct of left-sided heart issues.
The statement provides a structured clinical framework for the evaluation, assessment, and treatment of right-sided cardiac dysfunction. By establishing these criteria, the HFSA aims to improve diagnostic accuracy and standard-of-care protocols for patients across the cardiovascular disease spectrum.
This update is intended to guide clinicians in identifying early signs of right heart failure, which experts note has often been under-recognized in broader cardiac patient populations. The new guidelines offer a standardized approach for medical professionals to improve patient outcomes through more targeted therapeutic interventions.